Circadian biomarkers in patients with bipolar disorder: promising putative predictors of lithium response

International Journal of Bipolar Disorders

Volumn 2, Issue 1, 2014, Pages

  Geoffroy, Pierre Alexis ^a,b,c,d   Etain, Bruno ^d,e,f   Sportiche, Sarah ^a,b,c,d   Bellivier, Frank ^a,b,c,d  

^a INSERM   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d FONDATION FONDAMENTAL   (France)

^e HENRI MONDOR HOSPITAL   (France)

^f INSERM U955   (France)

Author keywords

Chronobiology; Circadian genes; Circadian rhythms; Lithium acetate; Lithium carbonate; Lithium salts; Mood stabilizers; Recurrences; Remission; Sleep

Indexed keywords

LITHIUM; MELATONIN;

ACTIMETRY; BIPOLAR DISORDER; CIRCADIAN RHYTHM; DISEASE PREDISPOSITION; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; LETTER; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; REMISSION; SLEEP DISORDER; SLEEP WAKING CYCLE; TREATMENT RESPONSE;

EID: 85026972349     PISSN: None     EISSN: 21947511     Source Type: Journal    
DOI: 10.1186/2194-7511-2-5     Document Type: Letter

References (43)

1. Epstein LJ, Kristo D, Strollo PJ Jr, Friedman N, Malhotra A, Patil SP, Ramar K, Rogers R, Schwab RJ, Weaver EM, Weinstein MD, Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine: Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults.J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med 2009, 5:263–276.
2. Baldessarini RJ, Tondo L: Does lithium treatment still work? Evidence of stable responses over three decades.Arch Gen Psychiatry 2000, 57:187–190.
3. Can A, Schulze TG, Gould TD: Molecular actions and clinical pharmacogenetics of lithium therapy.Pharmacol Biochem Behav 2014. doi:10.1016/j.pbb.2014.02.004
4. Collins PY, Patel V, Joestl SS, March D, Insel TR, Daar AS, Anderson W, Dhansay MA, Phillips A, Shurin S, Walport M, Ewart W, Savill SJ, Bordin IA, Costello EJ, Durkin M, Fairburn C, Glass RI, Hall W, Huang Y, Hyman SE, Jamison K, Kaaya S, Kapur S, Kleinman A, Ogunniyi A, Otero-Ojeda A, Poo M-M, Ravindranath V, Scientific Advisory Board and the Executive Committee of the Grand Challenges on Global Mental Health, et al.: Grand challenges in global mental health.Nature 2011, 475:27–30. doi:10.1038/475027a
5. Etain B, Milhiet V, Bellivier F, Leboyer M: Genetics of circadian rhythms and mood spectrum disorders.Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol 2011,21(Suppl 4):S676–682. doi:10.1016/j.euroneuro.2011.07.007
6. Etain B, Dumaine A, Bellivier F, Pagan C, Francelle L, Goubran-Botros H, Moreno S, Deshommes J, Moustafa K, Le Dudal K, Mathieu F, Henry C, Kahn J-P, Launay J-M, Mühleisen TW, Cichon S, Bourgeron T, Leboyer M, Jamain S: Genetic and functional abnormalities of the melatonin biosynthesis pathway in patients with bipolar disorder.Hum Mol Genet 2012. doi:10.1093/hmg/dds227
7. Garnham J, Munro A, Slaney C, Macdougall M, Passmore M, Duffy A, O'Donovan C, Teehan A, Alda M: Prophylactic treatment response in bipolar disorder: results of a naturalistic observation study.J Affect Disord 2007, 104:185–190. doi:10.1016/j.jad.2007.03.003
8. Geddes JR, Miklowitz DJ: Treatment of bipolar disorder.Lancet 2013, 381:1672–1682. doi:10.1016/S0140–6736(13)60857–0
9. Geoffroy PA, Bellivier F, Scott J, Boudebesse C, Lajnef M, Gard S, Kahn J-P, Azorin J-M, Henry C, Leboyer M, Etain B: Bipolar disorder with seasonal pattern: clinical characteristics and gender influences.Chronobiol Int 2013a. doi:10.3109/07420528.2013.800091
10. Geoffroy PA, Boudebesse C, Henrion A, Jamain S, Henry C, Leboyer M, Bellivier F, Etain B: An ASMT variant associated with bipolar disorder influences sleep and circadian rhythms: a pilot study.Genes Brain Behav 2013. doi:10.1111/gbb.12103
11. Geoffroy PA, Etain B, Scott J, Henry C, Jamain S, Leboyer M, Bellivier F: Reconsideration of bipolar disorder as a developmental disorder: importance of the time of onset.J Physiol Paris 2013. doi:10.1016/j.jphysparis.2013.03.006
12. Geoffroy PA, Bellivier F, Leboyer M, Etain B: Can the response to mood stabilizers be predicted in bipolar disorder?Front Biosci Elite Ed 2014, 120–138. doi:10.2741/E696
13. Goodwin GM: Evidence-based guidelines for treating bipolar disorder: revised second edition–recommendations from the British Association for Psychopharmacology.J Psychopharmacol Oxf Engl 2009, 23:346–388. doi:10.1177/0269881109102919
14. Grof P: Sixty years of lithium responders.Neuropsychobiology 2010, 62:8–16. doi:10.1159/000314305
15. Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller H-J, Kasper S: The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania.World J Biol Psychiatry Off J World Fed Soc Biol Psychiatry 2009, 10:85–116. doi:10.1080/15622970902823202
16. Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller H-J, Kasper S: The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression.World J Biol Psychiatry Off J World Fed Soc Biol Psychiatry 2010, 11:81–109. doi:10.3109/15622970903555881
17. Hallam KT, Olver JS, Chambers V, Begg DP, McGrath C, Norman TR: The heritability of melatonin secretion and sensitivity to bright nocturnal light in twins.Psychoneuroendocrinology 2006, 31:867–875. doi:10.1016/j.psyneuen.2006.04.004
18. Harvey AG: Sleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulation.Am J Psychiatry 2008, 165:820–829. doi:10.1176/appi.ajp.2008.08010098
19. Hasler G, Drevets WC, Gould TD, Gottesman II, Manji HK: Toward constructing an endophenotype strategy for bipolar disorders.Biol Psychiatry 2006, 60:93–105. doi:10.1016/j.biopsych.2005.11.006
20. Johnsson A, Engelmann W, Pflug B, Klemke W: Period lengthening of human circadian rhythms by lithium carbonate, a prophylactic for depressive disorders.Int J Chronobiol 1983, 8:129–147.
21. Jope RS, Roh M-S: Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions.Curr Drug Targets 2006, 7:1421–1434.
22. Kato T, Kubota M, Kasahara T: Animal models of bipolar disorder.Neurosci Biobehav Rev 2007, 31:832–842. doi:10.1016/j.neubiorev.2007.03.003
23. Kleindienst N, Engel R, Greil W: Which clinical factors predict response to prophylactic lithium? A systematic review for bipolar disorders.Bipolar Disord 2005, 7:404–417. doi:10.1111/j.1399–5618.2005.00244.x
24. Klemfuss H: Rhythms and the pharmacology of lithium.Pharmacol Ther 1992, 56:53–78.
25. Klemfuss H, Kripke DF: Antimanic drugs stabilize hamster circadian rhythms.Psychiatry Res 1995, 57:215–222.
26. Maj M, Pirozzi R, Magliano L: Nonresponse to reinstituted lithium prophylaxis in previously responsive bipolar patients: prevalence and predictors.Am J Psychiatry 1995, 152:1810–1811.
27. McClung CA: Circadian genes, rhythms and the biology of mood disorders.Pharmacol Ther 2007, 114:222–232. doi:10.1016/j.pharmthera.2007.02.003
28. McClung CA: How might circadian rhythms control mood? Let me count the ways.Biol Psychiatry 2013. doi:10.1016/j.biopsych.2013.02.019
29. Milhiet V, Etain B, Boudebesse C, Bellivier F: Circadian biomarkers, circadian genes and bipolar disorders.J Physiol Paris 2011. doi:10.1016/j.jphysparis.2011.07.002
30. Morgenthaler T, Alessi C, Friedman L, Owens J, Kapur V, Boehlecke B, Brown T, Chesson A Jr, Coleman J, Lee-Chiong T, Pancer J, Swick TJ: Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007.Sleep 2007, 30:519–529.
31. Morgenthaler TI, Lee-Chiong T, Alessi C, Friedman L, Aurora RN, Boehlecke B, Brown T, Chesson AL Jr, Kapur V, Maganti R, Owens J, Pancer J, Swick TJ, Zak R: Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders.An Am Acad Sleep Med Rep Sleep 2007, 30:1445–1459.
32. Müller-Oerlinghausen B, Ahrens B, Grof E, Grof P, Lenz G, Schou M, Simhandl C, Thau K, Volk J, Wolf R: The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness.Acta Psychiatr Scand 1992, 86:218–222.
33. Pfennig A, Schlattmann P, Alda M, Grof P, Glenn T, Müller-Oerlinghausen B, Suwalska A, Rybakowski J, Willich SN, Bauer M, Berghöfer A: Influence of atypical features on the quality of prophylactic effectiveness of long-term lithium treatment in bipolar disorders.Bipolar Disord 2010, 12:390–396. doi:10.1111/j.1399–5618.2010.00826.x
34. Pflug B, Engelmann W: Chronobiology of lithium–studies on healthy, middle-aged women.Pharmacopsychiatry 1987, 20:181–188. doi:10.1055/s-2007–1017099
35. Phillips ML, Kupfer DJ: Bipolar disorder diagnosis: challenges and future directions.Lancet 2013, 381:1663–1671. doi:10.1016/S0140–6736(13)60989–7
36. Prickaerts J, Moechars D, Cryns K, Lenaerts I, van Craenendonck H, Goris I, Daneels G, Bouwknecht JA, Steckler T: Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania.J Neurosci Off J Soc Neurosci 2006, 26:9022–9029. doi:10.1523/JNEUROSCI.5216–05.2006
37. Roybal K, Theobold D, Graham A, DiNieri JA, Russo SJ, Krishnan V, Chakravarty S, Peevey J, Oehrlein N, Birnbaum S, Vitaterna MH, Orsulak P, Takahashi JS, Nestler EJ, Carlezon WA Jr, McClung CA: Mania-like behavior induced by disruption of CLOCK.Proc Natl Acad Sci U S A 2007, 104:6406–6411. doi:10.1073/pnas.0609625104
38. Rybakowski JK, Dembinska D, Kliwicki S, Akiskal KK, Akiskal HH: TEMPS-A and long-term lithium response: positive correlation with hyperthymic temperament.J Affect Disord 2013, 145:187–189. doi:10.1016/j.jad.2012.07.028
39. Schulze TG, Alda M, Adli M, Akula N, Ardau R, Bui ET, Chillotti C, Cichon S, Czerski P, Del Zompo M, Detera-Wadleigh SD, Grof P, Gruber O, Hashimoto R, Hauser J, Hoban R, Iwata N, Kassem L, Kato T, Kittel-Schneider S, Kliwicki S, Kelsoe JR, Kusumi I, Laje G, Leckband SG, Manchia M, Macqueen G, Masui T, Ozaki N, Perlis RH, et al.: The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment.Neuropsychobiology 2010, 62:72–78. doi:10.1159/000314708
40. Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M: Clinical guideline for the evaluation and management of chronic insomnia in adults.J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med 2008, 4:487–504.
41. Solomon DA, Keitner GI, Miller IW, Shea MT, Keller MB: Course of illness and maintenance treatments for patients with bipolar disorder.J Clin Psychiatry 1995, 56:5–13.
42. Yatham LN, Kennedy SH, Schaffer A, Parikh V, Beaulieu S, O'Donovan C, MacQueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Young AH, Alda M, Milev R, Vieta E, Calabrese JR, Berk M, Ha K, Kapczinski F: Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.Bipolar Disord 2009, 11:225–255. doi:10.1111/j.1399–5618.2009.00672.x
43. Yerevanian BI, Choi YM: Impact of psychotropic drugs on suicide and suicidal behaviors.Bipolar Disord 2013, 15:594–621. doi:10.1111/bdi.12098